This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Ingrid Teige, Ph.D.
Vice President Preclinical at BioInvent International AB
Speaker

Agenda Sessions

  • BI-1910 - A TNFR2 Agonist Activating Tumor Targeting T cells for Cancer Immunotherapy

    09:00